October 27, 2022
UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.
November 19, 2020
…in Development of Flu Drugs Researchers demonstrate molecular binding mechanism that could change approach to designing influenza treatments There is no hole-in-one drug treatment when it comes to the flu, but that doesn’t stop scientists from trying to sink one. Especially since as many as one in five Americans gets…
March 24, 2020
Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.
July 30, 2024
Researchers from University of California San Diego and el Colegio de la Frontera Norte in Mexico have revealed a link between illicit fentanyl use and the transmission of hepatitis C (HCV) among people who inject drugs in San Diego, California and Tijuana, Mexico.
May 19, 2016
…Medical School have launched OpenZika, a project to find drug candidates to treat Zika, a fast spreading virus that the World Health Organization has declared a global public health emergency.
April 17, 2012
Karl Y. Hostetler, MD, has been selected as the recipient of the 2012 Gertrude Elion Memorial Lecture Award by the International Society of Antiviral Research. Hostetler is a professor of medicine in the Divisions of Infectious Diseases and Endocrinology at the UC San Diego School of Medicine.
February 11, 2022
Researchers at UC San Diego School of Medicine have presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by “drug tourism” unabated by the closure of the international border due to the COVID-19 pandemic.
January 5, 2021
Researchers describe the biology of three families of RNA viruses including Coronavirus, Ebola, and Zika and the natural products that have been shown to have capabilities to inhibit them. The review provides a guide that could accelerate drug discovery in response to future epidemics.
October 23, 2014
…focused upon finding a drug capable of slowing – if not stopping – the infectious, deadly and terrifying virus. UC Health System Forms Ebola Response Task Force The West Africa Ebola outbreak in Sierra Leone, Guinea and Liberia and the infection of U.S. health care workers has captured media attention…
October 31, 2022
UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.
